| 2020-06 | Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia | 김용희 |
| 2017-02 | Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation | 김용희 |
| 2013-12 | Hypoxic resistance of hypodermically transplanted pancreatic islets by using cell-absorbable antioxidant Tat-metallothionein | 김용희 |
| 2015-10 | Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex | 김용희 |
| 2013-08 | Injectable microsphere/hydrogel hybrid system containing heat shock protein as therapy in a murine myocardial infarction model | 김용희 |
| 2011-05 | Intracellular organelle-targeted non-viral gene delivery systems | 김용희 |
| 2015-10 | Intracellular transduction of TAT-Hsp27 fusion protein enhancing cell survival and regeneration capacity of cardiac stem cells in acute myocardial infarction | 김용희 |
| 2012-02 | Low-Molecular-Weight Methylcellulose-Based Thermo-reversible Gel/Pluronic Micelle Combination System for Local and Sustained Docetaxel Delivery | 김용희 |
| 2022-04 | Metformin booster adipocyte-targeted gene therapy for the treatment of obesity and related metabolic syndromes | 김용희 |
| 2017-01 | Mononuclear phagocytes as a target, not a barrier, for drug delivery | 김용희 |
| 2011-04 | Nano Self-Assembly of Recombinant Human Gelatin Conjugated with alpha-Tocopheryl Succinate for Hsp90 Inhibitor, 17-AAG, Delivery | 김용희 |
| 2014-01 | Nanobiomaterials for pharmaceutical and medical applications | 김용희 |
| 2014-01 | Natural and synthetic biomaterials for controlled drug delivery | 김용희 |
| 2019-10 | Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells | 김용희 |
| 2019-10 | Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells | 김용희 |
| 2014-10 | Oligopeptide complex for targeted non-viral gene delivery to adipocytes | 김용희 |
| 2013-02 | Protective effects of protein transduction domain-metallothionein fusion proteins against hypoxia- and oxidative stress-induced apoptosis in an ischemia/reperfusion rat model | 김용희 |
| 2021-04 | Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy | 김용희 |
| 2018-03 | Recent challenges and advances in genetically-engineered cell therapy | 김용희 |
| 2015-01 | Reducible Poly(Oligo-d-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model | 김용희 |
| 2018-08 | Regeneration of Anti-Hypoxic Myocardial Cells by Transduction of Mesenchymal Stem Cell-Derived Exosomes Containing Tat-Metallothionein Fusion Proteins | 김용희 |
| 2021-02 | RNA interference-mediated suppression of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis | 김용희 |
| 2016-10 | RNAi-mediated silencing of TNF-alpha converting enzyme to down-regulate soluble TNF-alpha production for treatment of acute and chronic colitis | 김용희 |
| 2012-03 | Self-Assembled Nanoparticles with Dual Effects of Passive Tumor Targeting and Cancer-Selective Anticancer Effects | 김용희 |
| 2013-02 | Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis | 김용희 |
| 2011-11 | Suicidal gene therapy against tumor using reducible poly (oligo-d-arginine) | 김용희 |
| 2011-12 | Suicide gene therapy using reducible poly (oligo-D-arginine) for the treatment of spinal cord tumors | 김용희 |
| 2018-04 | Surfactant-free solubilization and systemic delivery of anti-cancer drug using low molecular weight methylcellulose | 김용희 |
| 2019-09 | Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance | 김용희 |
| 2014-09 | Thermo-reversible injectable gel based on enzymatically-chopped low molecular weight methylcellulose for exenatide and FGF 21 delivery to treat types 1 and 2 diabetes | 김용희 |
